Heteroaryl derivatives as CFTR modulators
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
1. The compound:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising
(i) the compound of claim 1 ; and
(ii) a pharmaceutically acceptable carrier.
3. The composition of claim 2 , further comprising an additional agent selected from the group consisting of a mucolytic agent, bronchodialator, an anti-biotic, an anti-infective agent, an anti-inflammatory agent, CFTR corrector, and a nutritional agent.